Form 4 Tracker
Dianthus Therapeutics, Inc. /DE/
DNTH

32 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 2 11:00 PMSimrat RandhawaEVP, Head of R&D
Sale
26,530$90.62$2.4M4,000(D)

View →

Jun 1, 2026Jun 1 8:13 PMSIMRAT RANDHAWA
Proposed Sale
26,530$93.01$2.5M—

View →

May 8, 2026May 11 9:00 PMPaula SoteropoulosDirector
Sale
599$85.47$51.2K0(D)

View →

Apr 9, 2026Apr 10 8:52 PMRyan SavitzEVP, CFO & CBO
Sale
8,224$89.84$738.8K0(D)

View →

Apr 9, 2026Apr 9 8:22 PMRYAN SAVITZ
Proposed Sale
8,224$87.48$719.4K—

View →

Mar 31, 2026Apr 1 9:26 PMRyan SavitzEVP, CFO & CBO
Sale
114,367$83.00$9.5M0(D)

View →

Mar 31, 2026Apr 1 9:26 PMPaula SoteropoulosDirector
Sale
599$80.11$48.0K0(D)

View →

Mar 31, 2026Mar 31 8:25 PMRYAN SAVITZ
Proposed Sale
114,367$79.45$9.1M—

View →

Mar 31, 2026Mar 31 8:21 PMPAULA C SOTEROPOULOS
Proposed Sale
1,198$79.45$95.2K—

View →

Mar 24, 2026Mar 26 10:00 PMPaula SoteropoulosDirector
Sale
27,594$78.05$2.2M0(D)

View →

Mar 24, 2026Mar 24 8:29 PMPAULA C SOTEROPOULOS
Proposed Sale
27,594$79.32$2.2M—

View →

Mar 12, 2026Mar 14 12:30 AMMarino GarciaDirector, CEO AND PRESIDENT
Sale
122,918$81.49$10.0M0(D)

View →

Mar 12, 2026Mar 14 12:30 AMEdward CarrCHIEF ACCOUNTING OFFICER
Sale
43,682$81.49$3.6M0(D)

View →

Mar 12, 2026Mar 14 12:30 AMSimrat RandhawaEVP, Head of R&D
Sale
33,830$81.48$2.8M0(D)

View →

Mar 12, 2026Mar 12 8:59 PMMARINO GARCIA
Proposed Sale
122,918$85.84$10.6M—

View →

Mar 12, 2026Mar 12 8:30 PMSIMRAT RANDHAWA
Proposed Sale
33,830$85.84$2.9M—

View →

Mar 12, 2026Mar 12 8:23 PMEDWARD CARR
Proposed Sale
43,682$85.84$3.7M—

View →

Dec 4, 2025Dec 4 9:42 PMRYAN SAVITZ
Proposed Sale
20,000$43.97$879.4K—

View →

Nov 13, 2025Nov 13 9:23 PMSIMRAT RANDHAWA
Proposed Sale
196,538$38.72$7.6M—

View →

Sep 9, 2025Sep 9 8:27 PMRYAN SAVITZ
Proposed Sale
20,000$31.80$636.0K—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 17, 2026Sep 18 8:36 PMEdward CarrCHIEF ACCOUNTING OFFICER
Option Exercise
20,000$17.8843,818(D)

View →

Sep 1, 2026Sep 3 8:30 PMSimrat RandhawaEVP, Head of R&D
Option Exercise
23,124$22.0787,500(D)

View →

Aug 19, 2026Aug 19 10:02 PMSimon ReadDirector
Option Exercise
2,778$18.3619,445(D)

View →

Aug 13, 2026Aug 14 8:30 PMAdam M VenessSVP, General Counsel and Sec.
Option Exercise
15,000$18.1773,240(D)

View →

Aug 10, 2026Aug 11 9:15 PMAnne McgeorgeDirector
Option Exercise
7,750$19.360(D)

View →

Aug 10, 2026Aug 11 9:10 PMSimon ReadDirector
Option Exercise
2,777$18.3622,223(D)

View →

Aug 10, 2026Aug 11 9:08 PMAdam M VenessSVP, General Counsel and Sec.
Option Exercise
16,167$17.8860,000(D)

View →

Aug 7, 2026Aug 11 9:08 PMAdam M VenessSVP, General Counsel and Sec.
Option Exercise
3,833$17.8876,167(D)

View →

Aug 7, 2026Aug 7 10:30 PMMarino GarciaDirector, CEO AND PRESIDENT
Option Exercise
166,000$8.44160,004(D)

View →

Jul 9, 2026Jul 13 9:00 PMRyan SavitzEVP, CFO & CBO
Option Exercise
31,249$21.7768,751(D)

View →

Jun 17, 2026Jun 18 8:30 PMAdam M VenessSVP, General Counsel and Sec.
Option Exercise
30,000$17.8880,000(D)

View →

Jun 1, 2026Jun 2 11:00 PMSimrat RandhawaEVP, Head of R&D
Option Exercise
26,530$22.0796,875(D)

View →

May 21, 2026May 22 8:30 PMSteven J. RomanoDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMSimon ReadDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMAlison Frances LawtonDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMAnne McgeorgeDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMSujay KangoDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMJonathan ViolinDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMPaula SoteropoulosDirector
Grant/Award
6,090$89.636,090(D)

View →

May 8, 2026May 11 9:00 PMPaula SoteropoulosDirector
Option Exercise
599$8.440(D)

View →

Page 1 of 2

Next →